Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Japan
  • Asset Class: Equity
  • Geographic Focus: Japan

Bank Al-Jazira Al-Mashareq Japanese Equities

+ Add to Watchlist

BAJAMJE:AB

117.65 USD 0.000.00%

As of 00:59:30 ET on 04/20/2015.

Snapshot for Bank Al-Jazira Al-Mashareq Japanese Equities (BAJAMJE)

Year To Date: +12.78% 3-Month: +10.13% 3-Year: +10.58% 52-Week Range: 96.75 - 120.37
1-Month: +0.07% 1-Year: +20.64% 5-Year: +6.55% Beta vs DJIM: 0.61

Mutual Fund Chart for BAJAMJE

No chart data available.
  • BAJAMJE:AB 120.34
  • 1M
  • 1Y
Interactive BAJAMJE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BAJAMJE

Bank Aljazira - Al Mashareq Japanese Equities Fund is an open-end fund incorporated in Saudi Arabia. The aim of the Fund is to achieve long-term capital growth. The Fund invests in a diversified portfolio of listed Japanese Shariah-compliant equities.

Inception Date: 04-16-2000 Telephone: Tel +966 12 669 2669
Managers: -
Web Site: www.baj.com.sa

Fundamentals for BAJAMJE

NAV (on 2015-04-20) 117.65
Assets (M) (on 2015-04-23) 62.21
Fund Leveraged N
Minimum Investment 2,000.00
Minimum Subsequent Investment 500.00

Dividends for BAJAMJE

No dividends reported

Fees & Expenses for BAJAMJE

Front Load 2.00
Back Load -
Current Mgmt Fee 1.50
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BAJAMJE

Filing Date: 02/28/2015
Name Position Value % of Total
Astellas Pharma Inc 85,319 1,354,535 2.350%
Chugai Pharmaceutical Co Ltd 38,817 1,181,615 2.050%
Murata Manufacturing Co Ltd 9,549 1,175,851 2.040%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil